SRSA
CELG

S.R. Schill & Associates’s Celgene Corp CELG Stock Holding History

S.R. Schill & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,946
Closed -$307K – 78
2017
Q4 		$307K Buy
2,946
+362
+14% +$40.8K 0.19% 60
2017
Q3 		$377K Buy
2,584
+31
+1% +$4.22K 0.23% 54
2017
Q2 		$332K Buy
2,553
+471
+23% +$57.7K 0.21% 56
2017
Q1 		$259K Buy
+2,082
New +$249K 0.17% 63

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

S.R. Schill & Associates's CELG Position: Q1 2018 in Review

S.R. Schill & Associates sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 2,946 shares — an estimated $307K sold.

S.R. Schill & Associates first reported a position in CELG in Q1 2017 and held it in 4 quarters. The position peaked at $377K in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • S.R. Schill & Associates reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • S.R. Schill & Associates sold 2,946 Celgene Corp shares in Q1 2018, an estimated $307K.
  • S.R. Schill & Associates first reported a position in Celgene Corp in Q1 2017 and held it in 4 quarters.
  • S.R. Schill & Associates's Celgene Corp position peaked at $377K in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on S.R. Schill & Associates's 13F filing for Q1 2018, filed 10 May 2018.